Stock Analysis of Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code GLAXO
Close 2618.60
Change -3.10 / 0.118 %
Volume 92299.00
Vol Change 5897.00 / 6.83 %
IndustryDrugs & Pharma
SectorHealthcare
TSR Strength Index
Technical StrengthBearish
Growth Index Low Growth Stock
Value Index Very Low Value Stock
Profitability Index Mild Profitability
Stability Index Excellent Stability


Fundamental View of Glaxosmithkline Pharmaceuticals Ltd.


Highs/Lows of Glaxosmithkline Pharmaceuticals Ltd.
PeriodOld priceStock ReturnNifty 50HighLowHigh DateLow Date
One Week2758.105.06 % 0.283 % 2760.002601.0027-Oct-2530-Oct-25
Two Week2742.904.53 % 0.0478 % 2795.902601.0023-Oct-2530-Oct-25
One Month2659.701.55 % 4.51 % 2795.902601.0023-Oct-2530-Oct-25
Three Month3162.6017.20 % 3.85 % 3184.302560.0001-Aug-2512-Aug-25
Six Months2964.6011.67 % 5.70 % 3515.702560.0005-Jun-2512-Aug-25
One year2712.253.45 % 6.27 % 3515.701921.0005-Jun-2503-Feb-25
Two year1423.3583.97 % 34.81 % 3515.701385.0505-Jun-2502-Nov-23
Five year1464.7578.77 % 120.93 % 3515.701227.0005-Jun-2503-May-23
Ten year1655.0758.22 % 218.90 % 3515.70962.6505-Jun-2513-Mar-20


Technical View of Glaxosmithkline Pharmaceuticals Ltd.






Charts of Glaxosmithkline Pharmaceuticals Ltd.


Returns of Glaxosmithkline Pharmaceuticals Ltd. with Peers
Period / StockGLAXOLAURUSLABSBIOCONANTHEM
1 Week-5.06%2.94%3.50%-1.37%
1 Mth-1.55%13.29%9.12%-6.71%
3 Mth-17.20%9.07%-4.93%-6.46%
6mth-11.67%57.93%15.63%-
1 Year-3.45%94.13%17.72%-
2 Year83.97%163.62%69.41%-
5 Years78.77%198.58%-7.80%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Glaxosmithkline Pharmaceuticals Ltd. with Peers
Ratio / StockGLAXOLAURUSLABSBIOCONANTHEM
PE46.6975.13120.610
P/B24.5811.631.660
ROA24.669.470.6620
ROE52.6415.681.660
Debt To Equity0.00380.6040.8230.0195
Revenue37492.10 M
8.56 %
55539.60 M
10.18 %
152617 M
3.43 %
18445.53 M
29.96 %
Net Income9275.80 M
56.12 %
3583.20 M
123.18 %
10133.00 M
0.900 %
4512.59 M
22.86 %


Technicals of Glaxosmithkline Pharmaceuticals Ltd. with Peers
Technical / StockGLAXOLAURUSLABSBIOCONANTHEM-
ADX15.8821.9315.6724.80
CMF-0.1250.1870.063-0.167
MFI41.4164.3476.0819.88
RSI31.0265.6261.1935.43
MACD Abv SignalFalseTrueTrueFalse
Price Above 50 MAFalseTrueTrueFalse-
Price Above 200 MAFalseTrueTrue-


About : GlaxoSmithKline Pharmaceuticals Limited


Address : GSK House, Mumbai, India, 400030
Tel : 91 22 2495 9595
URL : https://india-pharma.gsk.com
Code : GLAXO, ISIN : INE159A01016, Exchange : NSE, Country : India
Fiscal Year End : March
Employee Count : 3113

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella; and Shingrix for prevention of herpes zoster and post-herpetic neuralgia. It also provides specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and Trelegy Ellipta for treating chronic obstructive pulmonary disease. In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, an oral antibiotic to treat bacterial infections; CobadexCZS to treat mineral and vitamins deficiency states in adult patients; Flutivate, a skin cream for adults, children and infants; Tenovate to treat inflammatory and pruritic manifestations of steroid responsive dermatosis; CALPOL to treat mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment of specific bacterial skin infections; BETNOVATE for skin conditions; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin associated with redness and itch. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is based in Mumbai, India.
Quick Overview of Birds Eye View